Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Champions Oncology (CSBR) Shares Issued (2016 - 2026)

Champions Oncology (CSBR) has 14 years of Shares Issued data on record, last reported at $207000.0 in Q4 2025.

  • For Q4 2025, Shares Issued fell 25.0% year-over-year to $207000.0; the TTM value through Oct 2025 reached $275000.0, down 0.72%, while the annual FY2025 figure was $320000.0, 26.48% up from the prior year.
  • Shares Issued reached $207000.0 in Q4 2025 per CSBR's latest filing, up from $24000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $276000.0 in Q4 2024 and bottomed at -$1000.0 in Q2 2023.
  • Average Shares Issued over 5 years is $73187.5, with a median of $31000.0 recorded in 2025.
  • Peak YoY movement for Shares Issued: soared 3300.0% in 2022, then plummeted 106.25% in 2023.
  • A 5-year view of Shares Issued shows it stood at $121000.0 in 2021, then dropped by 28.93% to $86000.0 in 2022, then surged by 179.07% to $240000.0 in 2023, then increased by 15.0% to $276000.0 in 2024, then decreased by 25.0% to $207000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Issued were $207000.0 in Q4 2025, $24000.0 in Q3 2025, and $6000.0 in Q2 2025.